Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02497105 · ClinicalTrials.gov registry record · NA
Ketogenic Diet Program for Epilepsy
A NA study, sponsored by Shriners Hospitals for Children.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02497105: Completed NA study, sponsored by Shriners Hospitals for Children.
NCT02497105 is a NA study that has completed, run by Shriners Hospitals for Children. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02497105, a NA study, has completed, sponsored by Shriners Hospitals for Children.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will assess the effectiveness of the ketogenic diet (high-fat, low-carbohydrate, and moderate protein) in treating epilepsy. Two study groups will be comprised of children with epilepsy (0-18 years of age) and whether or not they receive the ketogenic diet - epilepsy/ketogenic diet and epilepsy/non-ketogenic diet.
Primary Outcome
Assess the number of epileptic seizures through review/analysis of responses to the seizure log (self-report)
Interventions
- OTHER Ketogenic Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-01-19 |
| Phase | NA |
What the finished NCT02497105 record still lists
NCT02497105 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Ketogenic Diet is the first listed.
NCT02497105 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02497105 about?
NCT02497105 is a clinical study titled "Ketogenic Diet Program for Epilepsy". This study will assess the effectiveness of the ketogenic diet (high-fat, low-carbohydrate, and moderate protein) in treating epilepsy. Two study groups will be comprised of children with epilepsy (0-18 years of age) and whether or not they receive the ketogenic diet - epilepsy/ketogenic diet and ep...
What is the current status of trial NCT02497105?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2015-01. Estimated completion is 2018-01-19.
What interventions are being tested in trial NCT02497105?
The interventions under investigation include: Ketogenic Diet (OTHER).
Who is sponsoring clinical trial NCT02497105?
This trial is sponsored by Shriners Hospitals for Children, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02497105's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia